Home
DNTH
DNTH News

Latest Dianthus Therapeutics Inc. (DNTH) News on September 17, 2025

Dianthus Therapeutics (DNTH) Is Up 40.2% After Positive Phase 2 Myasthenia Gravis Data and $251M Equity Raise

Simply Wall St.

4 days ago

Dianthus Therapeutics (DNTH) Is Up 40.2% After Positive Phase 2 Myasthenia Gravis Data and $251M Equity Raise

MT Newswires

5 days ago

Stifel Adjusts Price Target on Dianthus Therapeutics to $65 From $52, Maintains Buy Rating

MT Newswires

5 days ago

Wedbush Raises Price Target on Dianthus Therapeutics to $44 From $42, Keeps Outperform Rating

MT Newswires

6 days ago

Dianthus Therapeutics Closes Upsized $288 Million Offering

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

GlobeNewswire

6 days ago

Dianthus Therapeutics, Inc. Announces Closing of its Upsized $288 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

MT Newswires

7 days ago

Dianthus Therapeutics Prices Upsized $251 Million Securities Offering

Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering

GlobeNewswire

8 days ago

Dianthus Therapeutics, Inc. Announces Pricing of Upsized $251 Million Underwritten Public Offering

Dianthus Therapeutics (DNTH) Hits New High as Drug Trial Sparks Optimism for Blockbuster Potential

Insider Monkey

8 days ago

Dianthus Therapeutics (DNTH) Hits New High as Drug Trial Sparks Optimism for Blockbuster Potential

Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference

GlobeNewswire

4 months ago

Dianthus Therapeutics to Webcast Presentation at the Jefferies Global Healthcare Conference

Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors

GlobeNewswire

4 months ago

Dianthus Therapeutics Appoints Simon Read, Ph.D., to Board of Directors

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results

GlobeNewswire

4 months ago

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results

Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September

GlobeNewswire

4 months ago

Dianthus Therapeutics Completes Enrollment of Phase 2 MaGic Trial of DNTH103 in Generalized Myasthenia Gravis With Top-Line Results Expected in September

Dianthus Therapeutics to Participate in Two Upcoming Investor Events

GlobeNewswire

5 months ago

Dianthus Therapeutics to Participate in Two Upcoming Investor Events

We're Not Very Worried About Dianthus Therapeutics' (NASDAQ:DNTH) Cash Burn Rate

Simply Wall St.

6 months ago

We're Not Very Worried About Dianthus Therapeutics' (NASDAQ:DNTH) Cash Burn Rate

Dianthus Therapeutics Full Year 2024 Earnings: Beats Expectations

Simply Wall St.

6 months ago

Dianthus Therapeutics Full Year 2024 Earnings: Beats Expectations

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results

GlobeNewswire

6 months ago

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY 2024 Financial Results

Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Directors

GlobeNewswire

6 months ago

Dianthus Therapeutics Strengthens Strategic Commercial Leadership With Appointment of John C. King as Chief Commercial Officer and Welcomes Sujay Kango, A Seasoned Commercial Leader, to Board of Directors

Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences

GlobeNewswire

7 months ago

Dianthus Therapeutics to Participate in Two Upcoming Investor Conferences

Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences

GlobeNewswire

8 months ago

Dianthus Therapeutics to Webcast Presentations at Two Investor Conferences

Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

8 months ago

Dianthus Therapeutics to Webcast Presentation at the 43rd Annual J.P. Morgan Healthcare Conference

Dianthus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

10 months ago

Dianthus Therapeutics Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

GlobeNewswire

10 months ago

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q3 Financial Results

Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences

GlobeNewswire

10 months ago

Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences

Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting

GlobeNewswire

a year ago

Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) Annual Meeting

Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September

GlobeNewswire

a year ago

Dianthus Therapeutics to Participate in Three Healthcare Investor Conferences in September

Dianthus Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Dianthus Therapeutics Second Quarter 2024 Earnings: Beats Expectations

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial Results

GlobeNewswire

a year ago

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q2 Financial Results

Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)

GlobeNewswire

a year ago

Dianthus Therapeutics Announces Two Poster Presentations for DNTH103 at the 10th Congress of the European Academy of Neurology (EAN)

Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)

GlobeNewswire

a year ago

Dianthus Therapeutics Announces FDA Clearance to Initiate Phase 2 Trial of DNTH103 in Multifocal Motor Neuropathy (MMN)

Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire

a year ago

Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference

Companies Like Dianthus Therapeutics (NASDAQ:DNTH) Are In A Position To Invest In Growth

Simply Wall St.

a year ago

Companies Like Dianthus Therapeutics (NASDAQ:DNTH) Are In A Position To Invest In Growth

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results

GlobeNewswire

a year ago

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q1 Financial Results

Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference

GlobeNewswire

a year ago

Dianthus Therapeutics to Participate in the Bank of America Securities 2024 Health Care Conference

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meeting

GlobeNewswire

a year ago

Dianthus Therapeutics Announces Oral Presentation for DNTH103 at the 2024 American Academy of Neurology (AAN) Annual Meeting

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

a year ago

Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Dianthus Therapeutics Insiders Added US$2.05m Of Stock To Their Holdings

Simply Wall St.

a year ago

Dianthus Therapeutics Insiders Added US$2.05m Of Stock To Their Holdings

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results

GlobeNewswire

a year ago

Dianthus Therapeutics Highlights Recent Business Achievements and Reports Q4 and FY2023 Financial Results

Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire

2 years ago

Dianthus Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)

GlobeNewswire

2 years ago

Dianthus Therapeutics Announces Initiation of Phase 2 MaGic Trial of DNTH103 In Generalized Myasthenia Gravis (gMG)

Business Wire

2 years ago

Early Repurchase(s)

Business Wire

2 years ago

Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds

Heritage Grocers Group Expands Senior Leadership Team, Adds DeAnn Brunts to Board of Directors

GlobeNewswire

2 years ago

Heritage Grocers Group Expands Senior Leadership Team, Adds DeAnn Brunts to Board of Directors

Petco Health and Wellness Company, Inc. to Host Fourth Quarter 2023 Earnings Conference Call on March 13, 2024

PR Newswire

2 years ago

Petco Health and Wellness Company, Inc. to Host Fourth Quarter 2023 Earnings Conference Call on March 13, 2024

AvalonBay Communities (AVB) Q4 FFO and Revenues Beat Estimates

Zacks

2 years ago

AvalonBay Communities (AVB) Q4 FFO and Revenues Beat Estimates

Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

GlobeNewswire

2 years ago

Cabaletta Bio to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

New Found Intercepts 27.5 g/t Au Over 7m & 8.69 g/t Au Over 12m at K2, Extends High-grade to Surface

Business Wire

2 years ago

New Found Intercepts 27.5 g/t Au Over 7m & 8.69 g/t Au Over 12m at K2, Extends High-grade to Surface

Why Applied Optoelectronics Stock Just Jumped 7%

Motley Fool

2 years ago

Why Applied Optoelectronics Stock Just Jumped 7%

JetBlue, Spirit seek expedited appeal of ruling blocking merger

Reuters

2 years ago

JetBlue, Spirit seek expedited appeal of ruling blocking merger

An Intrinsic Calculation For Covenant Logistics Group, Inc. (NASDAQ:CVLG) Suggests It's 25% Undervalued

Simply Wall St.

2 years ago

An Intrinsic Calculation For Covenant Logistics Group, Inc. (NASDAQ:CVLG) Suggests It's 25% Undervalued

MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability

ACCESSWIRE

2 years ago

MorphoSys Reports Preliminary 2023 Monjuvi U.S. Net Product Sales and Gross Margin, Provides 2024 Financial Guidance and Reduces Financial Liability

Bel Fuse (BELFB) Declines More Than Market: Some Information for Investors

Zacks

2 years ago

Bel Fuse (BELFB) Declines More Than Market: Some Information for Investors

Q3 Rundown: VeriSign (NASDAQ:VRSN) Vs Other E-commerce Software Stocks

StockStory

2 years ago

Q3 Rundown: VeriSign (NASDAQ:VRSN) Vs Other E-commerce Software Stocks

Relative Strength: 3 Buy-Rated Small-Caps Worth a Look

Zacks

2 years ago

Relative Strength: 3 Buy-Rated Small-Caps Worth a Look

Covenant Logistics Group, Inc. (NASDAQ:CVLG) Q4 2023 Earnings Call Transcript

Insider Monkey

2 years ago

Covenant Logistics Group, Inc. (NASDAQ:CVLG) Q4 2023 Earnings Call Transcript

WisdomTree Announces Say Platform for Fourth Quarter 2023 Earnings is Live

Business Wire

2 years ago

WisdomTree Announces Say Platform for Fourth Quarter 2023 Earnings is Live

Abbott (ABT) Q4 Earnings Match Estimates

Zacks

2 years ago

Abbott (ABT) Q4 Earnings Match Estimates

Newsfile

2 years ago

IAMGOLD Reports Fourth Quarter 2023 Production Results and Commissioning Progress at Côté Gold

Archer Daniels (ADM) Delays Earning Release, Revises Outlook

Zacks

2 years ago

Archer Daniels (ADM) Delays Earning Release, Revises Outlook

15 Small-Cap Stocks with High Potential

Insider Monkey

2 years ago

15 Small-Cap Stocks with High Potential

3 Overlooked Small-Cap Stocks Poised to Skyrocket Soon

InvestorPlace

2 years ago

3 Overlooked Small-Cap Stocks Poised to Skyrocket Soon

How Did Allegiant Travel Company's (NASDAQ:ALGT) 13% ROE Fare Against The Industry?

Simply Wall St.

2 years ago

How Did Allegiant Travel Company's (NASDAQ:ALGT) 13% ROE Fare Against The Industry?

China’s Export Controls Might Trigger a U.S. Graphite Boom

Oilprice.com

2 years ago

China’s Export Controls Might Trigger a U.S. Graphite Boom

OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023

GlobeNewswire

2 years ago

OrthoPediatrics Corp. Announces Preliminary Unaudited Financial Highlights for the Fourth Quarter & Full Year 2023

Institutional investors in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) have had a wonderful week after share price increased 24%

Simply Wall St.

2 years ago

Institutional investors in Dianthus Therapeutics, Inc. (NASDAQ:DNTH) have had a wonderful week after share price increased 24%

3 Strong Buys From the Refining & Marketing MLP Industry

Zacks

2 years ago

3 Strong Buys From the Refining & Marketing MLP Industry

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

GlobeNewswire

2 years ago

Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)

Charles River Associates (CRA) Appoints New Board Director and Announces Upcoming Changes to Committee Chairs

Business Wire

2 years ago

Charles River Associates (CRA) Appoints New Board Director and Announces Upcoming Changes to Committee Chairs

MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

GlobeNewswire

2 years ago

MannKind Corporation to Present at 42nd Annual J.P. Morgan Healthcare Conference

Sprott (TSE:SII) shareholders have earned a 16% CAGR over the last five years

Simply Wall St.

2 years ago

Sprott (TSE:SII) shareholders have earned a 16% CAGR over the last five years

Here's Why We're Watching Dianthus Therapeutics' (NASDAQ:DNTH) Cash Burn Situation

Simply Wall St.

2 years ago

Here's Why We're Watching Dianthus Therapeutics' (NASDAQ:DNTH) Cash Burn Situation

Investors in Kornit Digital (NASDAQ:KRNT) have unfortunately lost 78% over the last three years

Simply Wall St.

2 years ago

Investors in Kornit Digital (NASDAQ:KRNT) have unfortunately lost 78% over the last three years

HireRight Launches New Global Digital Identity Solution

Business Wire

2 years ago

HireRight Launches New Global Digital Identity Solution

Criteo (NASDAQ:CRTO) shareholders have earned a 9.1% CAGR over the last three years

Simply Wall St.

2 years ago

Criteo (NASDAQ:CRTO) shareholders have earned a 9.1% CAGR over the last three years

WalkMe (WKME) Upgraded to Buy: Here's Why

Zacks

2 years ago

WalkMe (WKME) Upgraded to Buy: Here's Why

NerdWallet, Inc. (NASDAQ:NRDS) insiders seem bullish, own 46% and have been buying more recently

Simply Wall St.

2 years ago

NerdWallet, Inc. (NASDAQ:NRDS) insiders seem bullish, own 46% and have been buying more recently

Insider Sell Alert: Director Robert Sledd Sells Shares of Universal Corp (UVV)

GuruFocus.com

2 years ago

Insider Sell Alert: Director Robert Sledd Sells Shares of Universal Corp (UVV)

Here's What's Concerning About Dril-Quip's (NYSE:DRQ) Returns On Capital

Simply Wall St.

2 years ago

Here's What's Concerning About Dril-Quip's (NYSE:DRQ) Returns On Capital

Wall Street Analysts See a 202.33% Upside in Relay Therapeutics, Inc. (RLAY): Can the Stock Really Move This High?

Zacks

2 years ago

Wall Street Analysts See a 202.33% Upside in Relay Therapeutics, Inc. (RLAY): Can the Stock Really Move This High?

Associated Press Finance

2 years ago

MAG Silver: Q3 Earnings Snapshot

These 5 Companies Were Huge Winners This Earnings Season. Can the Good Times Keep Rolling?

Motley Fool

2 years ago

These 5 Companies Were Huge Winners This Earnings Season. Can the Good Times Keep Rolling?

Thomson Reuters StreetEvents

2 years ago

Q3 2023 Supernus Pharmaceuticals Inc Earnings Call

Maravai LifeSciences Announces November 2023 Investor Conference Schedule

GlobeNewswire

2 years ago

Maravai LifeSciences Announces November 2023 Investor Conference Schedule

Supernus (SUPN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks

2 years ago

Supernus (SUPN) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

National Research Corporation Announces Third Quarter 2023 Results

GlobeNewswire

2 years ago

National Research Corporation Announces Third Quarter 2023 Results

Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates

Zacks

2 years ago

Cerus (CERS) Reports Q3 Loss, Lags Revenue Estimates

Share on Social Networks: